FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Roger Guillemin

Research Profile

Anatomy

Living Beings

Rats
Sheep

Chemicals & Drugs

Genes & Molecular Sequences

Amino Acid Sequences

Procedures

Co-author Network

Publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Roger Guillemin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Roger Guillemin
A conversation with Roger Guillemin. Interview by Greg Lemke.
Annual review of physiology 2013;75():1-22.
2011: Roger Guillemin
Neuroendocrinology: a short historical review.
Annals of the New York Academy of Sciences 2011;1220():1-5.
2010: Roger Guillemin
"en guise d'introduction ...".
Progress in brain research 2010;182():vii-viii.
2010: Roger Guillemin
"en guise d'introduction ...".
Progress in brain research 2010;181():vii-viii.
2008: Roger Guillemin
Somatostatin: the beginnings, 1972.
Molecular and cellular endocrinology 2008;286(1-2):3-4.
2008: Roger Guillemin; M H Perrin
Neuroendocrinology: past, present and future.
Annales d'endocrinologie 2008;69(2):160.
2006: Roger Guillemin
Basic research and the practice of medicine.
Annales de cardiologie et d'angéiologie 2006;55(2):63.
2006: Roger Guillemin
Acromegaly, day one and now, 120 years later.
Neuroendocrinology 2006;83(3-4):136-8.
2005: Roger Guillemin
Hypothalamic hormones a.k.a. hypothalamic releasing factors.
The Journal of endocrinology 2005;184(1):11-28.
2004: Roger Guillemin
Neuroendocrine basis of human disease.
Annals of the New York Academy of Sciences 2004;1038():131-7.
2001: K J Arrow; Julius Axelrod; franccesca villella; P Berg; John M Bishop; N Bloembergen; Herbert C Brown; J Cibelli; S Cohen; L N Cooper; E J Corey; J W Cronin; Robert F Curl; R Dulbecco; E H Fischer; V L Fitch; Robert W Fogel; J I Friedman; R F Furchgott; M Gell-Mann; W Gilbert; A Gilman; D Glaser; S L Glashow; R M Green; Paul Greengard; Roger Guillemin; L Hayflick; Herbert A Hauptman; J J Heckman; Alan J Heeger; Dudley R Herschbach; David H Hubel; R Hulse; Eric R Kandel; Jerome Karle; L R Klein; W Kohn; A Kornberg; Edwin G Krebs; R P Lanza; R Laughlin; L Lederman; D M Lee; E Lewis; William N Lipscomb; R A Marcus; D McFadden; RB Merrifield; R Merton; F Modigliani; M J Molina; F Murad; Marshall Nirenberg; D C North; George A Olah; D Osheroff; GE Palade; M Perl; N F Ramsey; B Richter; Richard J Roberts; P A Samuelson; M Schwartz; Phillip A Sharp; Richard E Smalley; Hamilton O Smith; R M Solow; H Stormer; H Taube; R Taylor; ED Thomas; J Tobin; Susumu Tonegawa; C Townes; James D Watson; S Weinberg; T H Weller; M D West; Eric Wieschaus; Torsten N Wiesel; R W Wilson
Nobel laureates' letter to President Bush.
Washington post (Washington, D.C. : 1974) 2001;():A02.
1995: Richard A Lerner; Roger Guillemin
Floyd Bloom: the next editor-in-chief of Science.
Science (New York, N.Y.) 1995;267(5203):1441-2.
1993: Roger Guillemin
Somatostatin: the early days.
Digestion 1993;54 Suppl 1():3-6.
1992: Roger Guillemin
Somatostatin: the early days.
Metabolism: clinical and experimental 1992;41(9 Suppl 2):2-4.
1988: S Cheifetz; N Ling; Roger Guillemin; Joan Massagué
A surface component on GH3 pituitary cells that recognizes transforming growth factor-beta, activin, and inhibin.
The Journal of biological chemistry 1988;263(33):17225-8.
1988: Juhani Leppäluoto; F Zeytin; N Ueno; S Y Ying; N Ling; Roger Guillemin
Myelin basic protein present in the acid extracts of rat hypothalami releases insulin and glucagon from isolated rat pancreatic islets.
Acta physiologica Scandinavica 1988;134(2):253-61.
1988: Shunichi Shimasaki; M Koga; F Esch; K Cooksey; M Mercado; A Koba; N Ueno; S Y Ying; N Ling; Roger Guillemin
Primary structure of the human follistatin precursor and its genomic organization.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(12):4218-22.
1988: Andrew Baird; David Schubert; N Ling; Roger Guillemin
Receptor- and heparin-binding domains of basic fibroblast growth factor.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(7):2324-8.
1988: S Y Ying; N Ling; Roger Guillemin
Inhibins and activins. Structures and radioimmunoassays.
Annals of the New York Academy of Sciences 1988;541():143-52.
1988: N Ling; N Ueno; S Y Ying; F Esch; S Shimasaki; M Hotta; P Cuevas; Roger Guillemin
Inhibins and activins.
Vitamins and hormones 1988;44():1-46.
1987: N Ueno; N Ling; S Y Ying; F Esch; S Shimasaki; Roger Guillemin
Isolation and partial characterization of follistatin: a single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(23):8282-6.
1987: S Y Ying; A Becker; G Swanson; P Tan; N Ling; F Esch; N Ueno; S Shimasaki; Roger Guillemin
Follistatin specifically inhibits pituitary follicle stimulating hormone release in vitro.
Biochemical and biophysical research communications 1987;149(1):133-9.
1987: F S Esch; Shunichi Shimasaki; M Mercado; K Cooksey; N Ling; S Ying; N Ueno; Roger Guillemin
Structural characterization of follistatin: a novel follicle-stimulating hormone release-inhibiting polypeptide from the gonad.
Molecular endocrinology (Baltimore, Md.) 1987;1(11):849-55.
1987: S Y Ying; J Czvik; A Becker; N Ling; N Ueno; Roger Guillemin
Secretion of follicle-stimulating hormone and production of inhibin are reciprocally related.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(13):4631-5.
1987: N Ueno; Andrew Baird; F Esch; N Ling; Roger Guillemin
Isolation and partial characterization of basic fibroblast growth factor from bovine testis.
Molecular and cellular endocrinology 1987;49(2-3):189-94.
1987: P Cuevas; S Y Ying; N Ling; N Ueno; F Esch; Roger Guillemin; D Healy; S Ta
Immunohistochemical detection of inhibin in the gonad.
Biochemical and biophysical research communications 1987;142(1):23-30.
1986: N Ueno; Andrew Baird; F Esch; S Shimasaki; N Ling; Roger Guillemin
Purification and partial characterization of a mitogenic factor from bovine liver: structural homology with basic fibroblast growth factor.
Regulatory peptides 1986;16(2):135-45.
1986: R Montesano; J D Vassalli; Andrew Baird; Roger Guillemin; L Orci
Basic fibroblast growth factor induces angiogenesis in vitro.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(19):7297-301.
1986: N Ling; S Y Ying; N Ueno; S Shimasaki; F Esch; M Hotta; Roger Guillemin
A homodimer of the beta-subunits of inhibin A stimulates the secretion of pituitary follicle stimulating hormone.
Biochemical and biophysical research communications 1986;138(3):1129-37.
1986: N Ueno; Andrew Baird; F Esch; N Ling; Roger Guillemin
Isolation of an amino terminal extended form of basic fibroblast growth factor.
Biochemical and biophysical research communications 1986;138(2):580-8.
1986: N Ling; S Y Ying; N Ueno; S Shimasaki; F Esch; M Hotta; Roger Guillemin
Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin.
Nature 1986;321(6072):779-82.
1986: S Y Ying; A Becker; N Ling; N Ueno; Roger Guillemin
Inhibin and beta type transforming growth factor (TGF beta) have opposite modulating effects on the follicle stimulating hormone (FSH)-induced aromatase activity of cultured rat granulosa cells.
Biochemical and biophysical research communications 1986;136(3):969-75.
1986: P Walicke; W M Cowan; N Ueno; Andrew Baird; Roger Guillemin
Fibroblast growth factor promotes survival of dissociated hippocampal neurons and enhances neurite extension.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(9):3012-6.
1986: S Y Ying; A Becker; Andrew Baird; N Ling; N Ueno; F Esch; Roger Guillemin
Type beta transforming growth factor (TGF-beta) is a potent stimulator of the basal secretion of follicle stimulating hormone (FSH) in a pituitary monolayer system.
Biochemical and biophysical research communications 1986;135(3):950-6.
1986: N Ling; Roger Guillemin
hpGRF-44-NH2, lot no. 92-81-5G-41-47, is (human) growth hormone-releasing factor containing no trace of (ovine) corticotropin-releasing factor.
Endocrinology 1986;118(3):1249-51.
1986: A Matsuki; T Kudo; H Ishihara; T Jin; T Taneichi; T Oyama; Roger Guillemin; N Ling
Plasma beta-endorphin levels during obstetrical analgesia with synthetic beta-endorphin.
Agressologie: revue internationale de physio-biologie et de pharmacologie appliquées aux effets de l'agression 1986;27(2):133-7.
1986: Andrew Baird; F Esch; P Mormède; N Ueno; N Ling; P Böhlen; S Y Ying; W B Wehrenberg; Roger Guillemin
Molecular characterization of fibroblast growth factor: distribution and biological activities in various tissues.
Recent progress in hormone research 1986;42():143-205.
1986: G Sassolas; Roger Guillemin
[Current status of somatocrinin, or GRF, a hypothalamic growth hormone-secreting factor].
Annales d'endocrinologie 1986;47(5):332-41.
1986: B Bloch; Andrew Baird; N Ling; Roger Guillemin
Immunohistochemical evidence that growth hormone-releasing factor (GRF) neurons contain an amidated peptide derived from cleavage of the carboxyl-terminal end of the GRF precursor.
Endocrinology 1986;118(1):156-62.
1985: Andrew Baird; F Esch; D Gospodarowicz; Roger Guillemin
Retina- and eye-derived endothelial cell growth factors: partial molecular characterization and identity with acidic and basic fibroblast growth factors.
Biochemistry 1985;24(27):7855-60.
1985: A J Mason; J S Hayflick; N Ling; F Esch; N Ueno; S Y Ying; Roger Guillemin; H Niall; P H Seeburg
Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-beta.
Nature 1985;318(6047):659-63.
1985: F Esch; N Ueno; Andrew Baird; F Hill; L Denoroy; N Ling; D Gospodarowicz; Roger Guillemin
Primary structure of bovine brain acidic fibroblast growth factor (FGF).
Biochemical and biophysical research communications 1985;133(2):554-62.
1985: N Ling; S Y Ying; N Ueno; F Esch; L Denoroy; Roger Guillemin
Isolation and partial characterization of a Mr 32,000 protein with inhibin activity from porcine follicular fluid.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(21):7217-21.
1985: Roger Guillemin
Walter B. Cannon memorial lecture. The language of polypeptides and the wisdom of the body.
The Physiologist 1985;28(5):391-6.
1985: F Esch; Andrew Baird; N Ling; N Ueno; F Hill; L Denoroy; R Klepper; D Gospodarowicz; P Böhlen; Roger Guillemin
Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(19):6507-11.
1985: Andrew Baird; F Culler; K L Jones; Roger Guillemin
Angiogenic factor in human ocular fluid.
Lancet 1985;2(8454):563.
1985: Andrew Baird; P Mormède; S Y Ying; W B Wehrenberg; N Ueno; N Ling; Roger Guillemin
A nonmitogenic pituitary function of fibroblast growth factor: regulation of thyrotropin and prolactin secretion.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(16):5545-9.
1985: Roger Guillemin
A personal reminiscence of Hans Selye.
Experientia 1985;41(5):560-1.
1985: Andrew Baird; P Böhlen; N Ling; Roger Guillemin
Radioimmunoassay for fibroblast growth factor (FGF): release by the bovine anterior pituitary in vitro.
Regulatory peptides 1985;10(4):309-17.
1985: N Ling; F Zeytin; P Böhlen; F Esch; P Brazeau; W B Wehrenberg; Andrew Baird; Roger Guillemin
Growth hormone releasing factors.
Annual review of biochemistry 1985;54():403-23.
1985: R Benoit; P Bohlen; N Ling; F Esch; Andrew Baird; S Y Ying; W B Wehrenberg; Roger Guillemin; J H Morrison; C Bakhit
Somatostatin-28 [1-12]-like peptides.
Advances in experimental medicine and biology 1985;188():89-107.
1985: W B Wehrenberg; Andrew Baird; F Zeytin; F Esch; P Böhlen; N Ling; S Y Ying; Roger Guillemin
Physiological studies with somatocrinin, a growth hormone-releasing factor.
Annual review of pharmacology and toxicology 1985;25():463-83.
1984: P Böhlen; W B Wehrenberg; F Esch; N Ling; P Brazeau; Roger Guillemin
Rat hypothalamic growth hormone-releasing factor: isolation, sequence analysis and total synthesis.
Biochemical and biophysical research communications 1984;125(3):1005-12.
1984: P Brazeau; P Böhlen; F Esch; N Ling; W B Wehrenberg; Roger Guillemin
Growth hormone-releasing factor from ovine and caprine hypothalamus: isolation, sequence analysis and total synthesis.
Biochemical and biophysical research communications 1984;125(2):606-14.
1984: F Esch; N Ling; P Bohlen; Andrew Baird; R Benoit; Roger Guillemin
Isolation and characterization of the bovine hypothalamic corticotropin-releasing factor.
Biochemical and biophysical research communications 1984;122(3):899-905.
1984: N Ling; F Esch; P Böhlen; Andrew Baird; Roger Guillemin
Isolation and characterization of caprine corticotropin-releasing factor.
Biochemical and biophysical research communications 1984;122(3):1218-24.
1984: N Ling; F Esch; P Böhlen; P Brazeau; W B Wehrenberg; Roger Guillemin
Isolation, primary structure, and synthesis of human hypothalamic somatocrinin: growth hormone-releasing factor.
Proceedings of the National Academy of Sciences of the United States of America 1984;81(14):4302-6.
1984: W B Wehrenberg; Andrew Baird; S Y Ying; C Rivier; N Ling; Roger Guillemin
Multiple stimulation of the adenohypophysis by combinations of hypothalamic releasing factors.
Endocrinology 1984;114(6):1995-2001.
1984: W B Wehrenberg; P Brazeau; N Ling; G Textor; Roger Guillemin
Pituitary growth hormone response in rats during a 24-hour infusion of growth hormone-releasing factor.
Endocrinology 1984;114(5):1613-6.
1984: Roger Guillemin; F Zeytin; N Ling; P Böhlen; F Esch; P Brazeau; B Bloch; W B Wehrenberg
Growth hormone-releasing factor: chemistry and physiology.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1984;175(4):407-13.
1984: P Y Hatron; J L Wemeau; Roger Guillemin; B Raviart; Philippe Vanhille; B Devulder
[Thyroid function in the nephrotic syndrome].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1984;5(1):35-42.
1984: B Bloch; N Ling; R Benoit; W B Wehrenberg; Roger Guillemin
Specific depletion of immunoreactive growth hormone-releasing factor by monosodium glutamate in rat median eminence.
Nature 1984;307(5948):272-3.
1984: Roger Guillemin; P Brazeau; P Böhlen; F Esch; N Ling; W B Wehrenberg; B Bloch; C Mougin; F Zeytin; Andrew Baird
Somatocrinin, the growth hormone releasing factor.
Recent progress in hormone research 1984;40():233-99.
1984: W B Wehrenberg; B Bloch; Z Chong-Li; P Brazeau; N Ling; Roger Guillemin
Pituitary response to growth hormone-releasing factor in rats with functional or anatomical lesions of the central nervous system that inhibit endogenous growth hormone secretion.
Regulatory peptides 1984;8(1):1-8.
1984: C Mougin; P Brazeau; N Ling; M Lewin; Roger Guillemin
[Roles of cyclic AMP and calcium in the mechanism of the release of growth hormone by somatocrinin].
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1984;299(4):83-8.
1983: F Esch; P Böhlen; N Ling; P Brazeau; Roger Guillemin
Isolation and characterization of the bovine hypothalamic growth hormone releasing factor.
Biochemical and biophysical research communications 1983;117(3):772-9.
1983: P Böhlen; F Esch; P Brazeau; N Ling; Roger Guillemin
Isolation and characterization of the porcine hypothalamic growth hormone releasing factor.
Biochemical and biophysical research communications 1983;116(2):726-34.
1983: S M Rosenthal; E A Schriock; S L Kaplan; Roger Guillemin; M M Grumbach
Synthetic human pancreas growth hormone-releasing factor (hpGRF1-44-NH2) stimulates growth hormone secretion in normal men.
The Journal of clinical endocrinology and metabolism 1983;57(3):677-9.
1983: P Böhlen; P Brazeau; B Bloch; N Ling; R Gaillard; Roger Guillemin
Human hypothalamic growth hormone releasing factor (GRF): evidence for two forms identical to tumor derived GRF-44-NH2 and GRF-40.
Biochemical and biophysical research communications 1983;114(3):930-6.
1983: P Böhlen; P Brazeau; F Esch; N Ling; W B Wehrenberg; Roger Guillemin
Human growth hormone releasing factor and somatostatin from two pancreatic tumors: isolation and characterization.
Regulatory peptides 1983;6(4):343-53.
1983: F S Esch; N C Ling; P Böhlen; S Y Ying; Roger Guillemin
Primary structure of PDC-109, a major protein constituent of bovine seminal plasma.
Biochemical and biophysical research communications 1983;113(3):861-7.
1983: W B Wehrenberg; P Brazeau; R Luben; N Ling; Roger Guillemin
A noninvasive functional lesion of the hypothalamo-pituitary axis for the study of growth hormone-releasing factor.
Neuroendocrinology 1983;36(6):489-91.
1983: W B Wehrenberg; R Benoit; Andrew Baird; Roger Guillemin
Inhibitory effects of cysteamine on neuroendocrine function.
Regulatory peptides 1983;6(2):137-45.
1983: Roger Guillemin
A personal reminiscence of Hans Selye.
Laboratory investigation; a journal of technical methods and pathology 1983;48(4):367-8.
1983: B Bloch; Andrew Baird; N Ling; R Benoit; Roger Guillemin
Immunohistochemical evidence that brain enkephalins arise from a precursor similar to adrenal preproenkephalin.
Brain research 1983;263(2):251-7.
1983: B Bloch; P Brazeau; N Ling; P Bohlen; F Esch; W B Wehrenberg; R Benoit; F Bloom; Roger Guillemin
Immunohistochemical detection of growth hormone-releasing factor in brain.
Nature 1983;301(5901):607-8.
1983: F S Esch; P Böhlen; N C Ling; P E Brazeau; W B Wehrenberg; Roger Guillemin
Primary structures of three human pancreas peptides with growth hormone-releasing activity.
The Journal of biological chemistry 1983;258(3):1806-12.
1983: G Sassolas; J A Chayvialle; C Partensky; G Berger; J Trouillas; F Berger; B Claustrat; R Cohen; C Girod; Roger Guillemin
[Acromegaly, clinical expression of the production of growth hormone releasing factor in pancreatic tumors].
Annales d'endocrinologie 1983;44(6):347-54.
1983: M Ravazzola; R Benoit; N Ling; Roger Guillemin; L Orci
Immunocytochemical localization of prosomatostatin fragments in maturing and mature secretory granules of pancreatic and gastrointestinal D cells.
Proceedings of the National Academy of Sciences of the United States of America 1983;80(1):215-8.
1982: R Benoit; N Ling; C Bakhit; J H Morrison; B Alford; Roger Guillemin
Somatostatin-28(1-12)-like immunoreactivity in the rat.
Endocrinology 1982;111(6):2149-51.
1982: P Brazeau; N Ling; P Böhlen; F Esch; S Y Ying; Roger Guillemin
Growth hormone releasing factor, somatocrinin, releases pituitary growth hormone in vitro.
Proceedings of the National Academy of Sciences of the United States of America 1982;79(24):7909-13.
1982: W B Wehrenberg; P Brazeau; R Luben; P Böhlen; Roger Guillemin
Inhibition of the pulsatile secretion of growth hormone by monoclonal antibodies to the hypothalamic growth hormone releasing factor (GRF).
Endocrinology 1982;111(6):2147-8.
1982: W B Wehrenberg; N Ling; P Brazeau; F Esch; P Böhlen; Andrew Baird; S Ying; Roger Guillemin
Somatocrinin, growth hormone releasing factor, stimulates secretion of growth hormone in anesthetized rats.
Biochemical and biophysical research communications 1982;109(2):382-7.
1982: P Brazeau; N Ling; F Esch; P Böhlen; C Mougin; Roger Guillemin
Somatocrinin (growth hormone releasing factor) in vitro bioactivity; Ca++ involvement, cAMP mediated action and additivity of effect with PGE2.
Biochemical and biophysical research communications 1982;109(2):588-94.
1982: W B Wehrenberg; N Ling; P Böhlen; F Esch; P Brazeau; Roger Guillemin
Physiological roles of somatocrinin and somatostatin in the regulation of growth hormone secretion.
Biochemical and biophysical research communications 1982;109(2):562-7.
1982: P Brazeau; Roger Guillemin; N Ling; J van Wyk; R Humbel
[Somatomedin inhibition of the growth hormone secretion stimulated by the hypothalamic factor somatocrinin or the synthetic peptide hpGRF].
Comptes rendus des séances de l'Académie des sciences. Série III, Sciences de la vie 1982;295(11):651-4.
1982: R A Luben; P Brazeau; P Böhlen; Roger Guillemin
Monoclonal antibodies to hypothalamic growth hormone-releasing factor with picomoles of antigen.
Science (New York, N.Y.) 1982;218(4575):887-9.
1982: F S Esch; P Böhlen; N C Ling; P E Brazeau; W B Wehrenberg; M O Thorner; M J Cronin; Roger Guillemin
Characterization of a 40 residue peptide from a human pancreatic tumor with growth hormone releasing activity.
Biochemical and biophysical research communications 1982;109(1):152-8.
1982: Roger Guillemin; P Brazeau; P Böhlen; F Esch; N Ling; W B Wehrenberg
Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly.
Science (New York, N.Y.) 1982;218(4572):585-7.
1982: Roger Guillemin
The brain as an endocrine organ--update 1981.
Endocrinologia experimentalis 1982;16(3-4):151-62.
1982: R Benoit; N Ling; B Alford; Roger Guillemin
Seven peptides derived from pro-somatostatin in rat brain.
Biochemical and biophysical research communications 1982;107(3):944-50.
1982: Andrew Baird; N Ling; P Böhlen; R Benoit; R Klepper; Roger Guillemin
Molecular forms of the putative enkephalin precursor BAM-12P in bovine adrenal, pituitary, and hypothalamus.
Proceedings of the National Academy of Sciences of the United States of America 1982;79(6):2023-5.
1982: R Benoit; P Böhlen; N Ling; A Briskin; F Esch; P Brazeau; S Y Ying; Roger Guillemin
Presence of somatostatin-28-(1-12) in hypothalamus and pancreas.
Proceedings of the National Academy of Sciences of the United States of America 1982;79(3):917-21.
1982: S Y Ying; N C Ling; F S Esch; Roger Guillemin; W B Watkins
Purification of gonadostatin from bovine seminal plasma (BSP).
Advances in experimental medicine and biology 1982;147():117-34.
1981: P Böhlen; P Brazeau; F Esch; N Ling; Roger Guillemin
Isolation and chemical characterization of somatostatin-28 from rat hypothalamus.
Regulatory peptides 1981;2(6):359-69.
1981: Roger Guillemin
Hypothalamic hypophysiotrophic peptides, known and unknown. The Sir Henry Dale lecture for 1980.
The Journal of endocrinology 1981;90(1):3p-10p.
1981: P Böhlen; F Esch; T Shibasaki; Andrew Baird; N Ling; Roger Guillemin
Isolation and characterization of a gamma 1-melanotropin-like peptide from bovine neurointermediate pituitary.
FEBS letters 1981;128(1):67-70.
1981: Lawrence J. Manderino; D Stenner; W Blanchard; S Nissen; J Gerich; N Ling; P Brazeau; P Bohlen; F Esch; Roger Guillemin
Selective effects of somatostatin-14, -25 and -28 on in vitro insulin and glucagon secretion.
Nature 1981;291(5810):76-7.
1981: P Bohlen; R Benoit; N Ling; Roger Guillemin; P Brazeau
Isolation and characterization of rat hypothalamic somatostatin-14.
Endocrinology 1981;108(5):2008-10.
1981: T Shibasaki; N Ling; Roger Guillemin; M Silver; F Bloom
The regional distribution of gamma 3-melanotropin-like peptides in bovine brain is correlated with adrenocorticotropin immunoreactivity but not with beta-endorphin.
Regulatory peptides 1981;2(1):43-52.
1981: S Y Ying; N Ling; P Böhlen; Roger Guillemin
Gonadocrinins: peptides in ovarian follicular fluid stimulating the secretion of pituitary gonadotropins.
Endocrinology 1981;108(4):1206-15.
1981: S Lavielle; N C Ling; R Saltman; Roger Guillemin
Synthesis of a glycotripeptide and a glycosomatostatin containing the 3-O-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)-L-serine residue.
Carbohydrate research 1981;89(2):229-36.
1981: S Lavielle; N C Ling; Roger Guillemin
Solid-phase synthesis of two glycopeptides containing the amino acid sequence 5 to 9 of somatostatin.
Carbohydrate research 1981;89(2):221-8.
1981: T Shibasaki; H Masui; G Sato; N Ling; Roger Guillemin
Secretion pattern of pro-opiomelanocortin-derived peptides by a pituitary adenoma from a patient with Cushing's disease.
The Journal of clinical endocrinology and metabolism 1981;52(2):350-3.
1981: P Brazeau; N Ling; F Esch; P Böhlen; R Benoit; Roger Guillemin
High biological activity of the synthetic replicates of somatostatin-28 and somatostatin-25.
Regulatory peptides 1981;1(4):255-64.
1980: I M Jackson; J L Bolaffi; Roger Guillemin
Presence of immunoreactive beta-endorphin and enkephalin-like material in the retina and other tissues of the frog, Rana pipiens.
General and comparative endocrinology 1980;42(4):505-8.
1980: F E Bloom; E L Battenberg; T Shibasaki; R Benoit; N Ling; Roger Guillemin
Localization of gamma-melanocyte stimulating hormone (gamma MSH) immunoreactivity in rat brain and pituitary.
Regulatory peptides 1980;1(3):205-22.
1980: R Benoit; P Böhlen; P Brazeau; N Ling; Roger Guillemin
Isolation and characterization of rat pancreatic somatostatin.
Endocrinology 1980;107(6):2127-9.
1980: F Esch; P Böhlen; N Ling; R Benoit; P Brazeau; Roger Guillemin
Primary structure of ovine hypothalamic somatostatin-28 and somatostatin-25.
Proceedings of the National Academy of Sciences of the United States of America 1980;77(11):6827-31.
1980: T Shibasaki; N Ling; Roger Guillemin
A radioimmunoassay for gamma 1-melanotropin and evidence that the smallest pituitary gamma-melanotropin is amidated at the COOH-terminus.
Biochemical and biophysical research communications 1980;96(3):1393-9.
1980: P Böhlen; F Castillo; N Ling; Roger Guillemin
Purification of peptides: an efficient procedure for the separation of peptides from amino acids and salt.
International journal of peptide and protein research 1980;16(4):306-10.
1980: P Böhlen; P Brazeau; R Benoit; N Ling; F Esch; Roger Guillemin
Isolation and amino acid composition of two somatostatin-like peptides from ovine hypothalamus: somatostatin-28 and somatostatin-25.
Biochemical and biophysical research communications 1980;96(2):725-34.
1980: N Ling; F Esch; D Davis; M Mercado; M Regno; P Bohlen; P Brazeau; Roger Guillemin
Solid phase synthesis of somatostatin-28.
Biochemical and biophysical research communications 1980;95(3):945-51.
1980: T Oyama; A Matsuki; T Taneichi; N Ling; Roger Guillemin
beta-Endorphin in obstetric analgesia.
American journal of obstetrics and gynecology 1980;137(5):613-6.
1980: P Brazeau; N Ling; F Esch; P Bohlen; R Benoît; Roger Guillemin
[High biological activity of the synthetic counterparts of hypothalamic somatostatin-28 and somatostatin-25].
Comptes rendus des séances de l'Académie des sciences. Série D, Sciences naturelles 1980;290(21):1369-71.
1980: T Shibasaki; N Ling; Roger Guillemin
Pituitary immunoreactive gamma-melanotropins are glycosylated oligopeptides.
Nature 1980;285(5764):416-7.
1980: J Rossier; Q Pittman; F Bloom; Roger Guillemin
Distribution of opioid peptides in the pituitary: a new hypothalamic-pars nervosa enkephalinergic pathway.
Federation proceedings 1980;39(8):2555-60.
1980: T Shibasaki; N Ling; Roger Guillemin
A radioimmunoassay for gamma-melanocyte stimulating hormone.
Life sciences 1980;26(21):1781-5.
1980: J H Julliard; T Shibasaki; N Ling; Roger Guillemin
High-molecular-weight immunoreactive beta-endorphin in extracts of human placenta is a fragment of immunoglobulin G.
Science (New York, N.Y.) 1980;208(4440):183-5.
1980: T Oyama; T Jin; R Yamaya; N Ling; Roger Guillemin
Profound analgesic effects of beta-endorphin in man.
Lancet 1980;1(8160):122-4.
1980: J Rossier; E French; Roger Guillemin; F E Bloom
On the mechanisms of the simultaneous release of immunoreactive beta-endorphin, ACTH, and prolactin by stress.
Advances in biochemical psychopharmacology 1980;22():363-75.
1980: J Rossier; E French; C Rivier; T Shibasaki; Roger Guillemin; F E Bloom
Stress-induced release of prolactin: blockade by dexamethasone and naloxone may indicate beta-endorphin mediation.
Proceedings of the National Academy of Sciences of the United States of America 1980;77(1):666-9.
1979: A Bayon; W J Shoemaker; F E Bloom; A Mauss; Roger Guillemin
Perinatal development of the endorphin- and enkephalin-containing systems in the rat brain.
Brain research 1979;179(1):93-101.
1979: J Rossier; E French; C Gros; S Minick; Roger Guillemin; F E Bloom
Adrenalectomy, dexamethasone or stress alters opioid peptides levels in rat anterior pituitary but not intermediate lobe or brain.
Life sciences 1979;25(24-25):2105-12.
1979: S Lavielle; N Ling; P Brazeau; R Benoit; T Wasada; D Harris; R Unger; Roger Guillemin
Synthesis and biological activity of glycosylated analogs of somatostatin.
Biochemical and biophysical research communications 1979;91(2):614-22.
1979: S Y Ying; Roger Guillemin
[Gonadostatin and gonadocrinin, polypeptides of ovarian origin with hypophysiotropic activity].
Comptes rendus des séances de l'Académie des sciences. Série D, Sciences naturelles 1979;289(13):943-6.
1979: N Ling; S Ying; S Minick; Roger Guillemin
Synthesis and biological activity of four gamma-melanotropin peptides derived from the cryuptic region of the adrenocorticotropin/beta-lipotropin precursor.
Life sciences 1979;25(20):1773-9.
1979: T Shibasaki; L Deftos; Roger Guillemin
Immunoreactive-beta-endorphin, -adrenocorticotropin and -calcitonin in extracts of anaplastic or differentiated (rat) medullary thyroid carcinoma.
Biochemical and biophysical research communications 1979;90(4):1266-73.
1979: M J Orloff; P V Hyde; L D Kosta; Roger Guillemin; R H Bell
The intestinal phase hormone.
World journal of surgery 1979;3(5):523-38.
1979: Roger Guillemin
Neuropeptides of the gut: a newly discovered major control system. Invited commentary.
World journal of surgery 1979;3(4):405-6.
1979: S Y Ying; Roger Guillemin
DTrp6-Pro9-NEt)-luteinising hormone-releasing factor inhibits follicular development in hypophysectomised rats.
Nature 1979;280(5723):593-5.
1979: M Chorev; R Shavitz; M Goodman; S Minick; Roger Guillemin
Partially modified retro-inverso-enkephalinamides: topochemical long-acting analogs in vitro and in vivo.
Science (New York, N.Y.) 1979;204(4398):1210-2.
1979: J Rossier; Joseph Rogers; T Shibasaki; Roger Guillemin; F E Bloom
Opioid peptides and alpha-melanocyte-stimulating hormone in genetically obese (ob/ob) mice during development.
Proceedings of the National Academy of Sciences of the United States of America 1979;76(4):2077-80.
1979: J Rossier; E Battenberg; Q Pittman; A Bayon; L Koda; R Miller; Roger Guillemin; F Bloom
Hypothalamic enkephalin neurones may regulate the neurohypophysis.
Nature 1979;277(5698):653-5.
1979: S Y Ying; Roger Guillemin
Dried Staphylococcus aureus as a rapid immunological separating agent in radioimmunoassays.
The Journal of clinical endocrinology and metabolism 1979;48(2):360-2.
1979: Y Hosobuchi; J Rossier; F E Bloom; Roger Guillemin
Stimulation of human periaqueductal gray for pain relief increases immunoreactive beta-endorphin in ventricular fluid.
Science (New York, N.Y.) 1979;203(4377):279-81.
1979: Roger Guillemin
New endocrinology of the brain.
Perspectives in biology and medicine 1979;22(2 Pt 2):S74-S80.
1978: W Vale; C Rivier; L Yang; S Minick; Roger Guillemin
Effects of purified hypothalamic corticotropin-releasing factor and other substances on the secretion of adrenocorticotropin and beta-endorphin-like immunoactivities in vitro.
Endocrinology 1978;103(5):1910-5.
1978: Roger Guillemin
Beta-lipotropin and endorphins: implications of current knowledge.
Hospital practice 1978;13(11):53-60.
1978: Roger Guillemin
Peptides in the brain: the new endocrinology of the neuron.
Science (New York, N.Y.) 1978;202(4366):390-402.
1978: S J Henriksen; F E Bloom; F McCoy; N Ling; Roger Guillemin
beta-Endorphin induces nonconvulsive limbic seizures.
Proceedings of the National Academy of Sciences of the United States of America 1978;75(10):5221-5.
1978: Roger Guillemin
Some thoughts on current research with somatostatin.
Metabolism: clinical and experimental 1978;27(9 Suppl 1):1453-61.
1978: L J Deftos; D Burton; Henry G Bone; B D Catherwood; J G Parthemore; R Y Moore; S Minick; Roger Guillemin
Immunoreactive calcitonin in the intermediate lobe of the pituitary gland.
Life sciences 1978;23(7):743-8.
1978: L J Deftos; D Burton; B D Catherwood; Henry G Bone; J G Parthemore; Roger Guillemin; W B Watkins; R Y Moore
Demonstration by immunoperoxidase histochemistry of calcitonin in the anterior lobe of the rat pituitary.
The Journal of clinical endocrinology and metabolism 1978;47(2):457-60.
1978: Roger Guillemin
The brain as an endocrine organ.
Neurosciences Research Program bulletin 1978;16 Suppl():1-25.
1978: N Ling; S Minick; Roger Guillemin
Amino-terminal extension analogs of methionine-enkephalin.
Biochemical and biophysical research communications 1978;83(2):565-70.
1978: A Bayon; J Rossier; A Mauss; F E Bloom; L L Iversen; N Ling; Roger Guillemin
In vitro release of [5-methionine]enkephalin and [5-leucine]-enkephalin from the rat globus pallidus.
Proceedings of the National Academy of Sciences of the United States of America 1978;75(7):3503-6.
1978: D N Orth; Roger Guillemin; N Ling; W E Nicholson
Immunoreactive endorphins, lipotropins and corticotropins in a human nonpituitary tumor: evidence for a common precursor.
The Journal of clinical endocrinology and metabolism 1978;46(5):849-52.
1978: J Rossier; Roger Guillemin; F Bloom
Foot shock induced stress decreases leu5-enkephalin immunoreactivity in rat hypothalamus.
European journal of pharmacology 1978;48(4):465-6.
1978: F Bloom; E Battenberg; J Rossier; N Ling; Roger Guillemin
Neurons containing beta-endorphin in rat brain exist separately from those containing enkephalin: immunocytochemical studies.
Proceedings of the National Academy of Sciences of the United States of America 1978;75(3):1591-5.
1978: Roger Guillemin
[Peptides of cerebral origin. Their growing importance in physiology and medicine].
Bulletin der Schweizerischen Akademie der Medizinischen Wissenschaften 1978;34(1-3):63-78.
1978: L L Iversen; S D Iversen; F E Bloom; T Vargo; Roger Guillemin
Release of enkephalin from rat globus pallidus in vitro.
Nature 1978;271(5646):679-81.
1978: P V Hyde; W P Skivolocki; Roger Guillemin; H J Sayers; M J Orloff
Augmentation of pentagastrin- and gastrin-stimulated acid secretion by the intestinal phase hormone.
Surgical forum 1978;29():392-4.
1978: Roger Guillemin
Biochemical and physiological correlates of hypothalamic peptides. The new endocrinology of the neuron.
Research publications - Association for Research in Nervous and Mental Disease 1978;56():155-94.
1978: Roger Guillemin
Control of adenohypophysial functions by peptides of the central nervous system.
Harvey lectures 1978;71():71-131.
1978: F E Bloom; J Rossier; E L Battenberg; A Bayon; E French; S J Henriksen; G R Siggins; D Segal; R Browne; N Ling; Roger Guillemin
beta-endorphin: cellular localization, electrophysiological and behavioral effects.
Advances in biochemical psychopharmacology 1978;18():89-109.
1977: J Rossier; Edward D French; C Rivier; N Ling; Roger Guillemin; F E Bloom
Foot-shock induced stress increases beta-endorphin levels in blood but not brain.
Nature 1977;270(5638):618-20.
1977: K W Kan; Andrew Baird; N G Seidah; M Lis; M Chrétien; N Ling; Roger Guillemin; S Solomon
Effects of peptides of pituitary origin on the formation of C21 steroid by fetal calf adrenal cells in culture.
Biochemical and biophysical research communications 1977;79(2):553-60.
1977: R E Weitzman; D A Fisher; S Minick; N Ling; Roger Guillemin
beta-Endorphin secretion of arginine vasopressin in vivo.
Endocrinology 1977;101(5):1643-6.
1977: J Rossier; T M Vargo; S Minick; N Ling; F E Bloom; Roger Guillemin
Regional dissociation of beta-endorphin and enkephalin contents in rat brain and pituitary.
Proceedings of the National Academy of Sciences of the United States of America 1977;74(11):5162-5.
1977: D S Segal; R G Browne; F Bloom; N Ling; Roger Guillemin
beta-Endorphin: endogenous opiate or neuroleptic?
Science (New York, N.Y.) 1977;198(4315):411-4.
1977: Roger Guillemin; N Ling; L Lazarus; R Burgus; S Minick; F Bloom; R Nicoll; G Siggins; D Segal
The endorphins, novel peptides of brain and hypophysial origin, with opiate-like activity: biochemical and biologic studies.
Annals of the New York Academy of Sciences 1977;297():131-57.
1977: Roger Guillemin; T Vargo; J Rossier; S Minick; N Ling; C Rivier; W Vale; F Bloom
beta-Endorphin and adrenocorticotropin are selected concomitantly by the pituitary gland.
Science (New York, N.Y.) 1977;197(4311):1367-9.
1977: J Rossier; A Bayon; T M Vargo; N Ling; Roger Guillemin; F Bloom
Radioimmunoassay of brain peptides: evaluation of a methodology for the assay of beta-endorphin and enkephalin.
Life sciences 1977;21(6):847-52.
1977: J P Gautray; A Jolivet; J P Vielh; Roger Guillemin
Presence of immunoassayable beta-endorphin in human amniotic fluid: elevation in cases of fetal distress.
American journal of obstetrics and gynecology 1977;129(2):211-2.
1977: Roger Guillemin
Purification, isolation, and primary structure of the hypothalamic luteinizing hormone-releasing factor of ovine origin. A historical account.
American journal of obstetrics and gynecology 1977;129(2):214-8.
1977: David S Janowsky; D S Segal; A Abrams; F Bloom; Roger Guillemin
Negative naloxone effects in schizophrenic patients.
Psychopharmacology 1977;53(3):295-7.
1977: David S Janowsky; D S Segal; F Bloom; A Abrams; Roger Guillemin
Lack of effect on naloxone on schizophrenic symptoms.
The American journal of psychiatry 1977;134(8):926-7.
1977: Roger Guillemin; N Ling; T Vargo
Radioimmunoassays for alpha-endorphin and beta-endorphin.
Biochemical and biophysical research communications 1977;77(1):361-6.
1977: R A Nicoll; G R Siggins; N Ling; F E Bloom; Roger Guillemin
Neuronal actions of endorphins and enkephalins among brain regions: a comparative microiontophoretic study.
Proceedings of the National Academy of Sciences of the United States of America 1977;74(6):2584-8.
1977: Roger Guillemin
Endorphins, brain peptides that act like opiates.
The New England journal of medicine 1977;296(4):226-8.
1977: Roger Guillemin; N Ling; R Burgus; F Bloom; D Segal
Characterization of the endorphins, novel hypothalamic and neurohypophysial peptides with opiate-like activity: evidence that they induce profound behavioral changes.
Psychoneuroendocrinology 1977;2(1):59-62.
1977: Roger Guillemin; H Estibal; A J Bonelli
[Trial use of aescine by drug dielectrolysis--apropos of 80 cases].
Electrodiagnostic-Thérapie 1977;14(2):51-4.
1977: F Bloom; E Battenberg; J Rossier; N Ling; J Leppaluoto; T M Vargo; Roger Guillemin
Endorphins are located in the intermediate and anterior lobes of the pituitary gland, not in the neurohypophysis.
Life sciences 1977;20(1):43-7.
1977: F Commandre; Roger Guillemin; G Revelli
[Electrotherapy in inflammatory osteo-articular reactions].
Electrodiagnostic-Thérapie 1977;14(2):37-49.
1977: F Commandre; P Kalaschnikoff; J Auzias; Roger Guillemin; J L Viani; J Lengrand; E Mercati
[Reflex algoneurodystrophies and high-frequency pulsations].
Electrodiagnostic-Thérapie 1977;14(1):9-18.
1977: Roger Guillemin; F Commandre; A J Bonelli
[Electrotherapy in circulatory disorders of the legs].
Electrodiagnostic-Thérapie 1977;14(1):5-8.
1977: C Rivier; W Vale; N Ling; M Brown; Roger Guillemin
Stimulation in vivo of the secretion of prolactin and growth hormone by beta-endorphin.
Endocrinology 1977;100(1):238-41.
1977: Roger Guillemin
The endocrinology of the neuron and the neural origin of endocrine cells.
Advances in experimental medicine and biology 1977;87():1-12.
1976: Roger Guillemin
Somatostatin inhibits the release of acetylcholine induced electrically in the myenteric plexus.
Endocrinology 1976;99(6):1653-4.
1976: F Bloom; D Segal; N Ling; Roger Guillemin
Endorphins: profound behavioral effects in rats suggest new etiological factors in mental illness.
Science (New York, N.Y.) 1976;194(4265):630-2.
1976: N Ling; R Burgus; Roger Guillemin
Isolation, primary structure, and synthesis of alpha-endorphin and gamma-endorphin, two peptides of hypothalamic-hypophysial origin with morphinomimetic activity.
Proceedings of the National Academy of Sciences of the United States of America 1976;73(11):3942-6.
1976: N Ling; Roger Guillemin
Morphinomimetic activity of synthetic fragments of beta-lipotropin and analogs.
Proceedings of the National Academy of Sciences of the United States of America 1976;73(9):3308-10.
1976: L Orci; O Baetens; C Rufener; M Brown; W Vale; Roger Guillemin
Evidence for immunoreactive neurotensin in dog intestinal mucosa.
Life sciences 1976;19(4):559-61.
1976: L H Lazarus; N Ling; Roger Guillemin
beta-Lipotropin as a prohormone for the morphinomimetic peptides endorphins and enkephalins.
Proceedings of the National Academy of Sciences of the United States of America 1976;73(6):2156-9.
1976: Roger Guillemin; N Ling; R Burgus
[Endorphins, hypothalamic and neurohypophysial peptides with morphinomimetic activity: isolation and molecular structure of alpha-endorphin].
Comptes rendus hebdomadaires des séances de l'Académie des sciences. Série D: Sciences naturelles 1976;282(8):783-5.
1976: Roger Guillemin
Physiological and clinical significance of hypothalamic and extrahypothalamic brain peptides.
Triangle; the Sandoz journal of medical science 1976;15(1):1-7.
1976: Roger Guillemin; J E Gerich
Somatostatin: physiological and clinical significance.
Annual review of medicine 1976;27():379-88.
1976: Roger Guillemin
The expanding significance of hypothalamic peptides, or, is endocrinology a branch of neuroendocrinology?
Recent progress in hormone research 1976;33():1-28.
1975: M Brown; J Rivier; W Vale; Roger Guillemin
Variability of the duration of inhibition of growth hormone release by Nalpha-acylated-des-(Ala1-Gly2)-H2somatostatin analogs.
Biochemical and biophysical research communications 1975;65(2):752-6.
1975: Roger Guillemin; M Fontaine
[The historic role of insulin in the physiopathology of the metabolic complications from pancreatic diabetes. Therapeutic implications for somatostatin].
Comptes rendus hebdomadaires des séances de l'Académie des sciences. Série D: Sciences naturelles 1975;280(20):2353-6.
1975: J E Gerich; M Lorenzi; S Hane; G Gustafson; Roger Guillemin; P H Forsham
Evidence for a physiologic role of pancreatic glucagon in human glucose homeostasis: studies with somatostatin.
Metabolism: clinical and experimental 1975;24(2):175-82.
1975: J Rivier; P Brazeau; W Vale; Roger Guillemin
Somatostatin analogs. Relative importance of the disulfide bridge and of the Ala-Gly side chain for biological activity.
Journal of medicinal chemistry 1975;18(2):123-6.
1975: Roger Guillemin
Significance of somatostatin, newcomer from the hypothalamus.
Voprosy biokhimii mozga 1975;10():117-21.
1975: W Vale; P Brazeau; C Rivier; M Brown; B Boss; J Rivier; R Burgus; N Ling; Roger Guillemin
Somatostatin.
Recent progress in hormone research 1975;31():365-97.
1974: P Brazeau; W Vale; R Burgus; Roger Guillemin
Isolation of somatostatin (a somatotropin release inhibiting factor) of ovine hypothalamic origin.
Canadian journal of biochemistry 1974;52(11):1067-72.
1974: J E Gerich; M Lorenzi; V Schneider; C W Kwan; J H Karam; Roger Guillemin; P H Forsham
Inhibition of pancreatic glucagon responses to arginine by somatostatin in normal man and in insulin-dependent diabetics.
Diabetes 1974;23(11):876-80.
1974: P Brazeau; W Vale; J Rivier; Roger Guillemin
Acylated des-(Ala1-Gly2)-somatostatin analogs: prolonged inhibition of growth hormone secretion.
Biochemical and biophysical research communications 1974;60(4):1202-7.
1974: R E Peterson; Roger Guillemin
The hormones of the hypothalamus.
The American journal of medicine 1974;57(4):591-600.
1974: W Vale; C Rivier; P Brazeau; Roger Guillemin
Effects of somatostatin on the secretion of thyrotropin and prolactin.
Endocrinology 1974;95(4):968-77.
1974: J E Gerich; M Lorenzi; V Schneider; J H Karam; J Rivier; Roger Guillemin; P H Forsham
Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications.
The New England journal of medicine 1974;291(11):544-7.
1974: R Luft; Roger Guillemin
Growth hormone and diabetes in man. Old concepts--new implications.
Diabetes 1974;23(9):783-7.
1974: P Brazeau; W Vale; J Rivier; Roger Guillemin
Biological potency of synthetic somatostatin in the oxidized and reduced form on the inhibition of secretion of growth hormone.
Life sciences 1974;15(2):351-7.
1974: T M Siler; S C Yen; W Vale; Roger Guillemin
Inhibition by somatostatin on the release of TSH induced in man by thyrotropin-releasing factor.
The Journal of clinical endocrinology and metabolism 1974;38(5):742-5.
1974: D C Parker; L G Rossman; T M Siler; J Rivier; Samuel S C Yen; Roger Guillemin
Inhibition of the sleep-related peak in physiologic human growth hormone release by somatostatin.
The Journal of clinical endocrinology and metabolism 1974;38(3):496-9.
1974: P Brazeau; J Rivier; W Vale; Roger Guillemin
Inhibition of growth hormone secretion in the rat by synthetic somatostatin.
Endocrinology 1974;94(1):184-7.
1974: Roger Guillemin
The hormones of the hypothalamus.
Progress in brain research 1974;41():117-32.
1973: N Ling; J Rivier; R Burgus; Roger Guillemin
Direct sequence determination of ovine luteinizing hormone releasing factor by mass spectrometry.
Biochemistry 1973;12(26):5305-10.
1973: T M Siler; G VandenBerg; Samuel S C Yen; P Brazeau; W Vale; Roger Guillemin
Inhibition of growth hormone release in humans by somatostatin.
The Journal of clinical endocrinology and metabolism 1973;37(4):632-4.
1973: Roger Guillemin; M Amoss; R Blackwell; R Burgus; G Grant; N Ling; M Monahan; J Rivier; W Vale
Polypeptide antagonists of the hypothalamic luteinizing hormone releasing factors.
Journal of reproduction and fertility. Supplement 1973;18():23-30.
1973: W Vale; R Blackwell; G Grant; Roger Guillemin
TRF and thyroid hormones on prolactin secretion by rat anterior pituitary cells in vitro.
Endocrinology 1973;93(1):26-33.
1973: G Grant; W Vale; Roger Guillemin
Characteristics of the pituitary binding sites for thyrotropin releasing factor.
Endocrinology 1973;92(6):1629-33.
1973: J Rivier; P Brazeau; W Vale; N Ling; R Burgus; C Gilon; J Yardley; Roger Guillemin
[Solid-phase total synthesis of a tetradecapeptide having the chemical and biological properties of somatostatine].
Comptes rendus hebdomadaires des séances de l'Académie des sciences. Série D: Sciences naturelles 1973;276(19):2737-40.
1973: J Rivier; W Vale; R Burgus; N Ling; M Amoss; R Blackwell; Roger Guillemin
Synthetic luteinizing hormone-releasing factor analogs. Series of short-chain amide LRF homologs converging to the amino terminus.
Journal of medicinal chemistry 1973;16(5):545-9.
1973: R Burgus; N Ling; M Butcher; Roger Guillemin
Primary structure of somatostatin, a hypothalamic peptide that inhibits the secretion of pituitary growth hormone.
Proceedings of the National Academy of Sciences of the United States of America 1973;70(3):684-8.
1973: C Rivier; W Vale; Roger Guillemin
An in vivo corticotropin-releasing factor (CRF) assay based on plasma levels of radioimmunoassayable ACTH.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1973;142(3):842-5.
1973: P Brazeau; W Vale; R Burgus; N Ling; M Butcher; J Rivier; Roger Guillemin
Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone.
Science (New York, N.Y.) 1973;179(4068):77-9.
1973: R Blackwell; W Vale; C Rivier; Roger Guillemin
Effect of perphenazine on the secretion of prolactin in vivo and in vitro.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1973;142(1):68-71.
1973: R Blackwell; W Vale; M Amoss; R Burgus; M Monahan; J Rivier; N Ling; Roger Guillemin
Lack of effect of native or synthetic LRF on secretion of prolactin in vitro.
The American journal of physiology 1973;224(1):176-9.
1973: R Blackwell; M Amoss; W Vale; R Burgus; J Rivier; M Monahan; N Ling; Roger Guillemin
Concomitant release of FSH and LH induced by native and synthetic LRF.
The American journal of physiology 1973;224(1):170-5.
1973: R Rebar; Samuel S C Yen; G VandenBerg; Frederick Naftolin; Y Ehara; S Engblom; K J Ryan; M Amoss; Roger Guillemin
Gonadotropin responses to synthetic LRF: dose-response relationship in men.
The Journal of clinical endocrinology and metabolism 1973;36(1):10-6.
1973: Roger Guillemin; W Vale; G Grant
Chemistry of the hypothalamic releasing factors. Studies on structure-function relationships in TRF and LRF.
Voprosy biokhimii mozga 1973;8():141-76.
1973: W Vale; G Grant; Roger Guillemin
Chemistry of the hypothalamic releasing factors--studies on structure-function relationships.
Frontiers in neuroendocrinology 1973;0(0):375-413.
1973: R E Blackwell; Roger Guillemin
Hypothalamic control of adenohypophysial secretions.
Annual review of physiology 1973;35():357-90.
1973: R Burgus; W Vale; J Rivier; M Monahan; N Ling; G Grant; M Amoss; Roger Guillemin
Chemistry of hypothalamic releasing factors.
Progress in brain research 1973;39():41-51.
1972: W Vale; P Brazeau; G Grant; A Nussey; R Burgus; J Rivier; N Ling; Roger Guillemin
[Preliminary observations on the mechanism of action of somatostatin, a hypothalamic factor inhibiting the secretion of growth hormone].
Comptes rendus hebdomadaires des séances de l'Académie des sciences. Série D: Sciences naturelles 1972;275(25):2913-6.
1972: Roger Guillemin; R Burgus
The hormones of the hypothalamus.
Scientific American 1972;227(5):24-33.
1972: Roger Guillemin; M Amoss; R Blackwell; J Rivier; N Ling; W Vale
On the biological activities of the synthetic tetrapeptide pyroglutamyl-tyrosyl-arginyl-tryptophanyl-amide.
Biochemical and biophysical research communications 1972;48(5):1093-9.
1972: W Vale; G Grant; M Amoss; R Blackwell; Roger Guillemin
Culture of enzymatically dispersed pituitary cells: functional validation of a method.
Endocrinology 1972;91(2):562-72.
1972: M Amoss; J Rivier; Roger Guillemin
Release of gonadotropins by oral administration of synthetic LRF or a tripeptide fragment of LRF.
The Journal of clinical endocrinology and metabolism 1972;35(1):175-7.
1972: Samuel S C Yen; R Rebar; G Van den Berg; Frederick Naftolin; Y Ehara; S Engblom; K J Ryan; K Benirschke; J Rivier; M Amoss; Roger Guillemin
Synthetic luteinizing hormone-releasing factor. A potent stimulator of gonadotropin release in man.
The Journal of clinical endocrinology and metabolism 1972;34(6):1108-11.
1972: W Vale; G Grant; J Rivier; M Monahan; M Amoss; R Blackwell; R Burgus; Roger Guillemin
Synthetic polypeptide antagonists of the hypothalamic luteinizing hormone releasing factor.
Science (New York, N.Y.) 1972;176(4037):933-4.
1972: M W Monahan; J Rivier; W Vale; Roger Guillemin; R Burgus
(Gly 2 )LRF and des-His 2 -LRF. The synthesis, purification, and characterization of two LRF analogues antagonistic to LRF.
Biochemical and biophysical research communications 1972;47(3):551-6.
1972: M Amoss; R Blackwell; Roger Guillemin
Stimulation of ovulation in the rabbit triggered by synthetic LRF.
The Journal of clinical endocrinology 1972;34():434-6.
1972: M Amoss; R Blackwell; Roger Guillemin
Stimulation of ovulation in the rabbit triggered by synthetic LRF.
The Journal of clinical endocrinology and metabolism 1972;34(2):434-6.
1972: G Grant; W Vale; Roger Guillemin
Interaction of thyrotropin releasing factor with membrane receptors of pituitary cells.
Biochemical and biophysical research communications 1972;46(1):28-34.
1972: Roger Guillemin
Physiology and chemistry of the hypothalamic releasing factors for gonadotropins: a new approach to fertility control.
Contraception 1972;5(1):1-19.
1972: R Burgus; M Butcher; M Amoss; N Ling; M Monahan; J Rivier; R Fellows; R Blackwell; W Vale; Roger Guillemin
Primary structure of the ovine hypothalamic luteinizing hormone-releasing factor (LRF) (LH-hypothalamus-LRF-gas chromatography-mass spectrometry-decapeptide-Edman degradation).
Proceedings of the National Academy of Sciences of the United States of America 1972;69(1):278-82.
1972: Norman Fleischer; Roger Guillemin
Clinical applications of hypothalamic-releasing factors.
Advances in internal medicine 1972;18():303-23.
1971: R Burgus; M Butcher; N Ling; M Monahan; J Rivier; R Fellows; M Amoss; R Blackwell; W Vale; Roger Guillemin
[Molecular structure of the hypothalamic factor (LRF) of ovine origin monitoring the secretion of pituitary gonadotropic hormone of luteinization (LH)].
Comptes rendus hebdomadaires des séances de l'Académie des sciences. Série D: Sciences naturelles 1971;273(18):1611-3.
1971: J C Porter; W Vale; R Burgus; R S Mical; Roger Guillemin
Release of TSH by TRF infused directly into a pituitary stalk portal vessel.
Endocrinology 1971;89(4):1054-6.
1971: M Monahan; J Rivier; R Burgus; M Amoss; R Blackwell; W Vale; Roger Guillemin
[Total synthesis by solid phase of a decapeptide stimulating the secretion of LH and FSH pituitary gonadotropins].
Comptes rendus hebdomadaires des séances de l'Académie des sciences. Série D: Sciences naturelles 1971;273(4):508-10.
1971: M Amoss; R Burgus; R Blackwell; W Vale; R Fellows; Roger Guillemin
Purification, amino acid composition and N-terminus of the hypothalamic luteinizing hormone releasing factor (LRF) of ovine origin.
Biochemical and biophysical research communications 1971;44(1):205-10.
1971: W W Vale; R Burgus; T F Dunn; Roger Guillemin
In vitro plasma inactivation of thyrotropin releasing factor (TRF) and related peptides. Its inhibition by various means and by the synthetic dipeptide PCA-His-OME.
Hormones 1971;2(4):193-203.
1971: Roger Guillemin; R Burgus; W Vale
The hypothalamic hypophysiotropic thyrotropin-releasing factor.
Vitamins and hormones 1971;29():1-39.
1971: Roger Guillemin; M Amoss; R Blackwell; R Burgus; G Grant; N Ling; M Monahan; J Rivier; W Vale
Polypeptides antagonists of the hypothalamic luteinizing hormone releasing factor.
Gynecologic investigation 1971;2(1):2-12.
1971: Roger Guillemin
Hypothalamic control of the secretion of adenohypophysial hormones.
Advances in metabolic disorders 1971;5():1-51.
1970: Norman Fleischer; R Burgus; W Vale; T Dunn; Roger Guillemin
Preliminary observations on the effect of synthetic thyrotropin releasing factor on plasma thyrotropin levels in man.
The Journal of clinical endocrinology and metabolism 1970;31(1):109-12.
1970: R Burgus; T F Dunn; D Desiderio; D N Ward; W Vale; Roger Guillemin
Characterization of ovine hypothalamic hypophysiotropic TSH-releasing factor.
Nature 1970;226(5243):321-5.
1970: R Burgus; T F Dunn; D M Desiderio; D N Ward; W Vale; Roger Guillemin; A M Felix; D Gillessen; R O Studer
Biological activity of synthetic polypeptide derivatives related to the structure of hypothalamic TRF.
Endocrinology 1970;86(3):573-82.
1970: W Vale; R Burgus; T F Dunn; Roger Guillemin
Release of TSH by oral administration of synthetic peptide derivatives with TRF activity.
The Journal of clinical endocrinology and metabolism 1970;30(1):148-50.
1970: R Burgus; Roger Guillemin
Hypothalamic releasing factors.
Annual review of biochemistry 1970;39():499-526.
1969: R Burgus; T F Dunn; D Desiderio; Roger Guillemin
[Molecular structure of the hypothalamic hypophysiotropic TRF factor of ovine origin: mass spectrometry demonstration of the PCA-His-Pro-NH2 sequence].
Comptes rendus hebdomadaires des séances de l'Académie des sciences. Série D: Sciences naturelles 1969;269(19):1870-3.
1969: R Burgus; T F Dunn; D Desiderio; W Vale; Roger Guillemin
[Synthetic polypeptide derivatives with TRF hypophysiotropic activity. New data].
Comptes rendus hebdomadaires des séances de l'Académie des sciences. Série D: Sciences naturelles 1969;269(2):226-8.
1969: Roger Guillemin
[Chymotrypsin in rheumatology. propos of372 cases].
Therapeutique (La Semaine des hôpitaux) 1969;45(6):639-43.
1969: M S Amoss; Roger Guillemin
Elevation of plasma LH concentrations induced by LH-releasing factor as measured by radioimmunoassay in the sheep.
Endocrinology 1969;84(6):1517-20.
1969: N W Rodger; J C Beck; R Burgus; Roger Guillemin
Variability of response in the bioassay for a hypothalamic somatotrophin releasing factor based on rat pituitary growth hormone content.
Endocrinology 1969;84(6):1373-83.
1969: R Burgus; T F Dunn; D N Ward; W Vale; M Amoss; Roger Guillemin
[Synthetic polypeptide derivatives with thyrotropin releasing factor hypophysiotropic activity].
Comptes rendus hebdomadaires des séances de l'Académie des sciences. Série D: Sciences naturelles 1969;268(16):2116-8.
1967: W Vale; Roger Guillemin
Potassium-induced stimulation of thyrotropin release in vitro. Requirement for presence of calcium and inhibition by thyroxine.
Experientia 1967;23(10):855-7.
1967: W Vale; R Burgus; Roger Guillemin
Presence of calcium ions as a requisite for the in vitro stimulation of TSH-release by hypothalamic TRF.
Experientia 1967;23(10):853-5.
1967: Roger Guillemin
Chemistry and physiology of hypothalamic releasing factors for gonadotrophins.
International journal of fertility 1967;12(4):359-67.
1967: Roger Guillemin
Hypothalamic control of concomitant secretion of ACTH and TSH.
Proceedings of the Royal Society of Medicine 1967;60(9):903.
1967: R Burgus; M S Amoss; Roger Guillemin
Solubility of the hypothalamic hormones TSH-releasing factor (TRF) and LH-releasing factor (LRF) in organic and alcoholic solvents.
Experientia 1967;23(6):417-8.
1967: W Vale; R Burgus; Roger Guillemin
Competition between thyroxine and TRF at the pituitary level in the release of TSH.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1967;125(1):210-3.
1967: P Ducommun; W Vale; E Sakiz; Roger Guillemin
Reversal of the inhibition of TSH secretion due to acute stress.
Endocrinology 1967;80(5):953-6.
1967: Roger Guillemin
The adenohypophysis and its hypothalamic control.
Annual review of physiology 1967;29():313-48.
1966: S Ducommun; Roger Guillemin
Maintenance of normal morphology in adenohypophysial transplants by topical administration of hypothalamic extracts with a simple method for transplantation in a pneumoderma pouch.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1966;122(4):1251-5.
1966: R Burgus; D N Ward; E Sakiz; Roger Guillemin
[Action of proteolytic enzymes on purified preparations of the TSH-hypophysiotropic hypothalamic hormone, TRF].
Comptes rendus hebdomadaires des séances de l'Académie des sciences. Série D: Sciences naturelles 1966;262(25):2643-5.
1966: P Ducommun; E Sakiz; Roger Guillemin
Dissociation of the acute secretions of thyrotropin and adrenocorticotropin.
The American journal of physiology 1966;210(6):1257-9.
1966: Roger Guillemin; R Burgus; E Sakiz; D N Ward
[Further data on the purification of the TSH-hypophysiotropic hypothalamic hormone, TRF].
Comptes rendus hebdomadaires des séances de l'Académie des sciences. Série D: Sciences naturelles 1966;262(21):2278-80.
1966: P Ducommun; E Sakiz; Roger Guillemin
Lability of plasma TSH levels in the rat in response to nonspecific exteroceptive stimuli.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1966;121(3):921-3.
1965: J Berato; F Commandre; R W Gilly; Roger Guillemin; P Lapras; B Daumas
[The corticotherapeutic escalade].
Rhumatologie 1965;17(9):349-52.
1965: P Ducommun; E Sakiz; Roger Guillemin
Increase of plasma TSH concentration following injection of purified hypothalamic TRF.
Endocrinology 1965;77(5):792-6.
1965: E Sakiz; Roger Guillemin
Inverse effects of purified hypothalamic TRF on the acute secretion of TSH and ACTH.
Endocrinology 1965;77(5):797-801.
1965: Roger Guillemin; D N Ward; E Sakiz
Filtration chromatography on substituted Sephadex in the purification of the hypothalamic hormone TRF (TSH-releasing factor).
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1965;120(1):256-8.
1965: Roger Guillemin; E Sakiz
A proposal for a reference standard preparation for the hypothalamic thyrotrophic hormone releasing factor.
Nature 1965;207(994):297-8.
1965: Roger Guillemin; E SAKIZ; D N WARD
FURTHER PURIFICATION OF TSH-RELEASING FACTOR (TRF) FROM SHEEP HYPOTHALAMIC TISSUES, WITH OBSERVATIONS ON THE AMINO ACID COMPOSITION.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1965;118():1132-7.
1965: H E HOFF; Roger Guillemin; E SAKIZ
CLAUDE BERNARD ON ANIMAL HEAT--AN UNPUBLISHED MANUSCRIPT AND SOME ORIGINAL NOTES.
Perspectives in biology and medicine 1965;8():347-68.
1965: Roger Guillemin
[Biochemistry and physiology of hypothalamic hormones].
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 1965;71():61-6.
1964: Roger Guillemin
HYPOTHALAMIC POLYPEPTIDES RELEASING PITUITARY HORMONES.
Metabolism: clinical and experimental 1964;13():SUPPL:1206-10.
1964: E SAKIZ; Roger Guillemin
[POTENTIATION OF THE BIOLOGICAL ACTION OF THE LRF HYPOTHALAMIC FACTOR OF BOVINE OR OVINE ORIGIN BY SYNTHETIC ARGININE-VASOPRESSIN].
Comptes rendus hebdomadaires des séances de l'Académie des sciences 1964;259():237-40.
1964: Roger Guillemin; E SAKIZ; D N WARD
[PURIFICATION OF THE HYPOTHALAMIC FACTOR (TRF) STIMULATING THE SECRETION OF THE THYROTROPIC PITUITARY HORMONE (TSH) BY THE COUNTER-CURRENT DISTRIBUTION METHOD].
Comptes rendus hebdomadaires des séances de l'Académie des sciences 1964;258():6567-8.
1964: E SAKIZ; Roger Guillemin
ON A METHOD FOR CALCULATION AND ANALYSIS OF RESULTS IN THE MCKENZIE ASSAY FOR THYROTROPIN (TSH).
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1964;115():856-60.
1964: Andrew V Schally; Roger Guillemin
SOME BIOLOGICAL AND CHEMICAL PROPERTIES OF A LYSINE- VASOPRESSIN DIMER.
The Journal of biological chemistry 1964;239():1038-41.
1964: Roger Guillemin
HYPOTHALAMIC FACTORS RELEASING PITUITARY HORMONES.
Recent progress in hormone research 1964;20():89-130.
1964: L LAPEYRE; F COMMANDRE; Roger Guillemin; J BERATO; G CREISSON
[BRUCELLAR SPONDYLO-DISKITIS. GENERAL REVIEW APROPOS OF 4 OBSERVATIONS].
Marseille médical 1964;101():915-24.
1964: H E HOFF; Roger Guillemin; E SAKIZ
CLAUDE BERNARD ON EXPERIMENTAL MEDICINE. SOME UNPUBLISHED NOTES.
Perspectives in biology and medicine 1964;8():30-49.
1963: R SCHIAVI; M JUTISZ; E SAKIZ; Roger Guillemin
STIMULATION OF OVULATION BY PURIFIED LH-RELEASING FACTOR (LRF) IN ANIMALS RENDERED ANOVULATORY BY HYPOTHALAMIC LESION.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1963;114():426-9.
1963: Roger Guillemin; E YAMAZAKI; D A GARD; M JUTISZ; E SAKIZ
IN VITRO SECRETION OF THYROTROPIN (TSH): STIMULATION BY A HYPOTHALAMIC PEPTIDE (TRF).
Endocrinology 1963;73():564-72.
1963: G W CLAYTON; L LIBRIK; R L GARDNER; Roger Guillemin
STUDIES ON THE CIRCADIAN RHYTHM OF PITUITARY ADRENOCORTICOTROPIC RELEASE IN MAN.
The Journal of clinical endocrinology and metabolism 1963;23():975-80.
1963: E YAMAZAKI; E SAKIZ; Roger Guillemin
AN IN VIVO BIOASSAY FOR TSH-RELEASING FACTOR (TRF).
Experientia 1963;19():480-1.
1963: L LAPEYRE; F COMMANDRE; G BARALIS; H TARAMASCO; Roger Guillemin
[SYMPATHETIC NEURO-OSTEO-TROPHIC SYNDROME CAUSED BY ZONA. GENERAL OBSERVATIONS ON A NEW CASE].
Rhumatologie 1963;15():227-37.
1963: E YAMAZAKI; E SAKIZ; Roger Guillemin
[CONCERNING THE EFFECT OF MELANOPHORETIC HORMONES ALPHA-MSH AND BETA-MSH ON THYROTROPIC AND THYROID FUNCTIONS].
Annales d'endocrinologie 1963;24():795-800.
1963: R COURRIER; A COLONGE; E SAKIZ; Roger Guillemin; M JUTISZ
[PRESENCE IN A SALINE EXTRACT OF HYPOTHALAMUS OF AN RSH TYPE FOLLICLE-STIMULATING ACTIVITY].
Comptes rendus hebdomadaires des séances de l'Académie des sciences 1963;257():1206-10.
1963: M JUTISZ; P DE LA LLOSA; E SAKIZ; E YAMAZAKI; Roger Guillemin
[Action of proteolytic enzymes on hypothalamic factors LRF and TRF stimulating the secretion of pituitary luteinizing (LH) and thyrotropic (TSH) hormones].
Comptes rendus des séances de la Société de biologie et de ses filiales 1963;157():235-7.
1963: E SAKIZ; Roger Guillemin
On the method of ovarian ascorbic acid depletion as a test for luteinizing hormone (LH).
Endocrinology 1963;72():804-12.
1963: Roger Guillemin; E SAKIZ
Quantitative study of the response to LH after hypophysectomy in the ovarian ascorbic acid depletion test: effect of prolactin.
Endocrinology 1963;72():813-6.
1963: Andrew V Schally; Roger Guillemin
Isolation and chemical characterization of a beta-CRF from pig posterior pituitary glands.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1963;112():1014-7.
1963: H E HOFF; Roger Guillemin
The first experiments on transfusion in France.
Journal of the history of medicine and allied sciences 1963;18():103-24.
1963: M JUTISZ; A BERAULT; E SAKIZ; Roger Guillemin
[Purification by carboxymethylcellulose chromatography of an hypothalamic factor (TRF) stimulating the secretion of thyrotropic pituitary hormone (TSH)].
Comptes rendus hebdomadaires des séances de l'Académie des sciences 1963;256():2925-7.
1963: Roger Guillemin
[Recent information on neuroendocrine chemical mediators originating in the central nervous system].
Bratislavské lekárske listy 1963;43():129-36.
1963: Roger Guillemin; M JUTISZ; E SAKIZ
[The partial purification of an hypothalamic factor (LRF) stimulating the secretion of pituitary luteinizing hormone (LH)].
Comptes rendus hebdomadaires des séances de l'Académie des sciences 1963;256():504-7.
1963: Roger Guillemin; Andrew V Schally
CONCENTRATION OF CORTICOTROPIN RELEASING FACTOR (CRF) IN ACID EXTRACTS OF SHEEP HYPOTHALAMUS BY GEL FILTRATION AND COUNTER CURRENT DISTRIBUTION.
Texas reports on biology and medicine 1963;21():541-5.
1963: V CRITCHLOW; H S LIPSCOMB; Roger Guillemin
Effect of CRF on maintenance of the adrenocorticotrophic function of anterior pituitary grafts.
The Journal of endocrinology 1963;25():465-72.
1963: Roger Guillemin
[On the nature of hypothalamic substances which control the secretion of anterior pituitary hormones].
Journal de physiologie 1963;55():7-44.
1963: Roger Guillemin
Hypothalamic neurohumors in the control of the functions of the anterior hypophysis.
Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie 1963;245():187-96.
1963: R W GILLY; B RENAULT; D SICARD; M WIART; Roger Guillemin
[Apropos of a case of myeloid splenomegaly with acute blastic transformation].
Marseille médical 1963;100():59-62.
1962: Andrew V Schally; H S LIPSCOMB; Roger Guillemin
Isolation and amino acid sequence of alpha2-corticotropin-releasing factor (alpha2-CRF) from hog pituitary glands.
Endocrinology 1962;71():164-73.
1962: D N WARD; E F WALBORG; H S LIPSCOMB; Roger Guillemin
Fractionation and analysis of monkey pituitary glands for posterior lobe hormones.
Acta endocrinologica 1962;40():283-9.
1962: E SAKIZ; Roger Guillemin
[Routine use of a large electronic computer in the mathematical analysis of results in experimental biology].
Comptes rendus hebdomadaires des séances de l'Académie des sciences 1962;254():3743-5.
1962: Roger Guillemin; A COLONGE; M JUTISZ; E SAKIZ
[Persistence of the biological activity of the luteinizing hormone after heating to 100 degrees C in an acid medium].
Comptes rendus hebdomadaires des séances de l'Académie des sciences 1962;254():3258-60.
1962: Andrew V Schally; H S LIPSCOMB; J M LONG; W E DEAR; Roger Guillemin
Chromatography and hormonal activities of dog hypothalamus.
Endocrinology 1962;70():478-80.
1962: Roger Guillemin; Andrew V Schally; H S LIPSCOMB; R N ANDERSEN; J M LONG
On the presence in hog hypothalamus of 3-corticotropin releasing factor, alpha- and beta-melanocyte stimulating hormones, adrenocorticotropin, lysine-vasopressin and oxytocin.
Endocrinology 1962;70():471-7.
1962: W A KRIVOY; Roger Guillemin
Antagonism of chlorpromazine by beta-melanocyte stimulating hormone (beta-MSH).
Experientia 1962;18():20-1.
1962: P MOUREN; J PASTOR; Roger Guillemin
[Acute porphyria with neurological manifestations in the course of 3 generations. Clinical and biological findings].
Marseille médical 1962;99():116-9.
1962: Andrew V Schally; S ROBINSON; Roger Guillemin
Quantitative aspects of percolation for the extraction of oxytocin and vasopressin.
Texas reports on biology and medicine 1962;20():680-2.
1961: R A LIEBELT; W DEAR; Roger Guillemin
Goldthioglucose-induced hypothalamic lesion and ACTH release.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1961;108():377-80.
1961: J M LONG; W A KRIVOY; Roger Guillemin
On a possible role of beta-melanocyte stimulating hormone (beta-MSH) in the central nervous system of the Mammalia: enzymatic inactivation in vitro of beta-MSH by brain tissue.
Endocrinology 1961;69():176-81.
1961: W A KRIVOY; Roger Guillemin
On a possible role of beta-melanocyte stimulating hormone (beta-MSH) in the central nervous system of the Mammalia: an effect of beta-MSH in the spinal cord of the cat.
Endocrinology 1961;69():170-5.
1961: R COURRIER; Roger Guillemin; A COLONGE; E SAKIZ
[Adrenal cortical response to hypophysial corticotropin hormone in the rat, as a function of sex. In vivo study].
Comptes rendus des séances de la Société de biologie et de ses filiales 1961;252():3520-4.
1961: J M LONG; Roger Guillemin
On the in vitrobioassay for measuring melanophoretic activity.
Experientia 1961;17():132-4.
1961: Roger Guillemin; Andrew V Schally
On the nature of the hypothalamic substance which controls the secretion of ACTH.
Acta neurovegetativa 1961;23():58-62.
1960: Andrew V Schally; R N ANDERSEN; H S LIPSCOMB; J M LONG; Roger Guillemin
Evidence for the existence of two corticotrophin-releasing factors, alpha and beta.
Nature 1960;188():192-3.
1960: Roger Guillemin
[Neurohumoral control of hypophysial adrenocorticotropic function].
Schweizerische medizinische Wochenschrift 1960;90():1328-9.
1960: Roger Guillemin; Andrew V Schally; R ANDERSEN; H LIPSCOMB; J LONG
[On the existence of 2 types of substances with hypophysiotropic activity: a-CRF and beta-CRF (corticotrophin-releasing factor)].
Comptes rendus hebdomadaires des séances de l'Académie des sciences 1960;250():4462-4.
1960: Andrew V Schally; R N ANDERSEN; J M LONG; Roger Guillemin
Isolation of alpha- and beta-melanocyte stimulating hormones (MSH) on a preparative scale.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1960;104():290-3.
1960: Roger Guillemin
Steroidogenic activities of purified alpha, beta, gamma, delta-corticotropins and pepsin degradation products of beta-corticotropin.
Endocrinology 1960;66():819-23.
1960: Roger Guillemin; W A KRIVOY
[Does the melanophoretic hormone beta-MSH play a role in the functions of the central nervous system in the higher mammals?].
Comptes rendus hebdomadaires des séances de l'Académie des sciences 1960;250():1117-9.
1960: W E DEAR; Roger Guillemin
Adrenal sensitivity to ACTH as a function of time after hypothalamic lesion and after hypophysectomy.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1960;103():356-8.
1960: Andrew V Schally; Roger Guillemin
Studies on corticotropin releasing factor: ion exchange chromotography of pituitary preparations.
Texas reports on biology and medicine 1960;18():133-46.
1959: Roger Guillemin; Andrew V Schally
Re-evaluation of a technique of pituitary incubation in vitro as an assay for corticotropin releasing factor.
Endocrinology 1959;65():555-62.
1959: Roger Guillemin
Hypothalamic control of the anterior hypophysis and its metabolic implications.
Diabetes 1959;8():352-7.
1959: S L STEELMAN; Roger Guillemin
Adrenocorticotropic activty of alpha melanocyte stimulating hormone (alpha-MSH).
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1959;101():600-1.
1959: Roger Guillemin; W E DEAR; R A LIEBELT
Nychthemeral variations in plasma free corticosteroid levels of the rat.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1959;101(2):394-5.
1959: B NICHOLS; Roger Guillemin
Endogenous and exogenous vasopressin on ACTH release.
Endocrinology 1959;64(6):914-20.
1959: Roger Guillemin; W E DEAR; B NICHOLS; H S LIPSCOMB
ACTH releasing activity in vivo of a CRF preparation and lysine vasopressin.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1959;101(1):107-11.
1959: Roger Guillemin; G W CLAYTON; H S LIPSCOMB; J D SMITH
Fluorometric measurement of rat plasma and adrenal corticosterone concentration; a note on technical details.
The Journal of laboratory and clinical medicine 1959;53(5):830-2.
1959: Roger Guillemin; C FORTIER; H S LIPSCOMB
Comparison of in vitro and in vivo assaying procedures for rat adenohypophysial corticotropin.
Endocrinology 1959;64(2):310-2.
1959: Andrew V Schally; Roger Guillemin
Concentration of corticotropin releasing factor by chromatography on carboxymethylcellulose.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1959;100(1):138-9.
1959: Andrew V Schally; H S LIPSCOMB; Roger Guillemin
Chromatographic separation of oxytocin and vasopressin on carboxymethylcellulose.
Biochimica et biophysica acta 1959;31(1):252-4.
1958: Roger Guillemin; B NICHOLS; H LIPSCOMB
[Hypothalamic factor in the secretion of ACTH; in vivo activity in animals with hypothalamic lesions or pharmacological block].
Comptes rendus hebdomadaires des séances de l'Académie des sciences 1958;247(19):1662-4.
1958: H E HOFF; Roger Guillemin; L A GEDDES
An 18th century scientist's observation of his own aphasia.
Bulletin of the history of medicine 1958;32(5):446-50.
1958: Roger Guillemin; G W CLAYTON; J D SMITH; H S LIPSCOMB
Measurement of free corticosteroids in rat plasma: physiological validation of a method.
Endocrinology 1958;63(3):349-58.
1957: G W CLAYTON; W R BELL; Roger Guillemin
Stimulation of ACTH-release in humans by non-pressor fraction from commercial extracts of posterior pituitary.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1957;96(3):777-9.
1957: D N WARD; Roger Guillemin
A simple method for preparation of highly purified vasopressin.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1957;96(3):568-70.
1957: H E HOFF; L A GEDDES; Roger Guillemin
The anemograph of Ons-en-Bray: an early self-registering predecessor of the kymograph with translations of original description and a biography of the inventor.
Journal of the history of medicine and allied sciences 1957;12(4):424-48.
1957: Roger Guillemin
[Hypothalamic control of ACTH secretion as observed in results of in vitro research].
Endokrinologie 1957;34(4):193-201.
1957: Roger Guillemin; W R HEARN; W R CHEEK; D E HOUSEHOLDER
Control of corticotrophin release: further studies with in vitro methods.
Endocrinology 1957;60(4):488-506.
1955: Roger Guillemin; B ROSENBERG
Humoral hypothalamic control of anterior pituitary: a study with combined tissue cultures.
Endocrinology 1955;57(5):599-607.
1955: Roger Guillemin; W R HEARN
ACTH release by in vitro pituitary; effect of pitressin and purified arginine-vasopressin.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1955;89(3):365-7.
1955: Roger Guillemin
A re-evaluation of acetylcholine, adrenaline, nor-adrenaline and histamine as possible mediators of the pituitary adreno-corticotrophic activation by stress.
Endocrinology 1955;56(3):248-55.
1954: M L MITCHELL; Roger Guillemin; H SALYE
The effect of somatotrophic hormone on the growth of normal and hypophysectomized guinea pigs.
Endocrinology 1954;54(1):111-4.
1953: Roger Guillemin; C CONTI
[Hypertension and hyalinosis due to methyl-androstenediol].
Folia endocrinologica; mensile di incretologia e incretoterapia 1953;6(2):183-8.
1953: Roger Guillemin; C FORTIER
Role of histamine in the hypothalamo-hypophyseal response to stress.
Transactions of the New York Academy of Sciences 1953;15(5):138-40.
1953: Roger Guillemin
[Hypertension after administration of adrenal cortex hormones and adaptation diseases].
Revue canadienne de biologie / éditée par l'Université de Montréal 1953;11(5):501-2.
1953: Roger Guillemin
[Not Available].
Revue canadienne de biologie / éditée par l'Université de Montréal 1953;11(5):500-1.
1953: A HORAVA; Roger Guillemin; H SELYE
[Effect of Reichstein's compound L on certain effects from the administration of an anterior pituitary lobe extract].
Annales d'endocrinologie 1953;14(5):779-83.
1953: C FORTIER; Roger Guillemin
[Study of the histaminergic mechanism of the stimulation of the pituitary-adrenal axis by stress].
Annales d'endocrinologie 1953;14(1):42-5.
1953: Roger Guillemin; C FORTIER
[Adaptation to the adrenocorticotropic effect of a synthetic antihistaminic (R.P. 3277)].
Annales d'endocrinologie 1953;14(1):38-41.
1952: Roger Guillemin
Alarm reaction and the general adaptation syndrome.
Annals of western medicine and surgery 1952;6(6):347-9.
1952: P DUCOMMUN; Roger Guillemin
[Hormonal pathogenesis of experimental cardiovascular lesions; cardiovascular lesions of adaptation diseases].
Médecine et hygiène 1952;10(219):211.
1952: H SELYE; Roger Guillemin
[General adaptation syndrome].
Maroc médical 1952;31(323):259-63.
1952: Roger Guillemin; H SELYE
[Nephrosclerotic and prophlogistic effect of various preparations of somatotropic hormones].
Annales d'endocrinologie 1952;13(5):836-40.
1951: Roger Guillemin
[Inhibiting action of phenergan (3277 R. P.) on the experimental hypertension syndrome produced by desoxycorticosterone acetate].
La semaine des hôpitaux : organe fondé par l'Association d'enseignement médical des hôpitaux de Paris 1951;27(61-62):2518-24.
1951: Roger Guillemin
[Parahydroxypropiophenone (H 365); a synthetic pituitary inhibitor?].
La Presse médicale 1951;59(39):799.
1951: Roger Guillemin; C FORTIER
Inhibition of DCA induced hypertension and hyalinosis by a drug acting on membrane permeability.
Endocrinology 1951;48(5):617-22.
1950: Roger Guillemin; H SELYE
[Action of mineral-corticoids on the behavior of the kidney towards vasopresor substances of angiotonin type].
Revue canadienne de biologie / éditée par l'Université de Montréal 1950;9(3):309.
1950: Roger Guillemin; H SELYE
[Mineral-corticoid inhibition of renal inactivation of vasopressive substances].
Annales d'endocrinologie 1950;11(3):270-5.